Successful use of extracorporeal membrane oxygenation in a human immunodeficiency virus infected patient with severe acute respiratory distress syndrome

Table 1 Nosocomial infections and treatment

ICU day	Bacteria				Fungus		Virus	CRP, mg/L	Treatment	MIC, mg/L	Administration route	Daily dose
ICU day	*Acinetobacter baumanii**	*Pseudomonas aeruginosa***	*Pseudomonas fluorescens*	*Enterobacter aerogenes*	*Candida glabrata*	*Candida parapsilosis*	*Cytomegalovirus* *(CMV)*	CRP, mg/L	Treatment	MIC, mg/L	Administration route	Daily dose
1	BAL/CAT				BAL/CAT		BAL/BL	93	Colistin	1	i.v.	13.5 m. IU
1	BAL/CAT				BAL/CAT		BAL/BL	93	Ganciclovir	-	i.v.	0.8 g
3	SP							165	Colistin	1	i.v.	13.5 m. IU
8					BAL			77	Anidulafungin	0.125	i.v.	0.1 g
11	BAL							151	Colistin	1	i.v.	13.5 m. IU
16		BAL						286	Ciprofloxacin	0.5	i.v.	1.2 g
24		BAL/BL						22	Ciprofloxacin	0.5	i.v.	2.4 g
24		BAL/BL						22	Colistin	2	i.v./inh	13.5/6 m. IU
28, 35, 39	BAL/ UR							149-157	Colistin	0.5-2	i.v./inh	13.5/9 m. IU
43	BAL/UR							162	Ampicillin Sulbactam	2	i.v.	36 g
51		BAL						98	Cefepim	4	i.v.	6 g
63	BAL							86	Colistin	0.5	i.v./inh	13.5/15 m. IU
65, 70						BL/ CAT		73	Amphotericin B	0.5	i.v.	0.08 g
75			CAT	CAT	CAT			90	Ciprofloxacin	0.38	i.v.	2.4 g
									Cefepim	4	i.v.	6 g
									Imipenem	1	i.v.	3 g
									Amphotericin B	0.19	i.v.	0.08 g
77				CAT				108	Imipenem	<0.25	i.v.	3 g

ICU – intensive care unit, CRP – C-reactive protein, MIC – minimal inhibitory concentration, BL – blood, BAL – bronchoalveolar lavage, CAT – catheter, UR – urine, i.v. – intravenous, inh.–inhaled, m. – million, IU – international units.
*Acinetobacter baumanii was carbapenems (Imipenem, Meropenem MIC 32 mg/L), aminoglycosyde (Amikacin MIC 256 mg/L, Gentamycin MIC 24 mg/L) and cephalosporin (Cefepim MIC 48 mg/L) resistant;
**Pseudomonas aeruginosa was carbapenems (Meropenem MIC 32 mg/L), cephalosporin (Cefepim MIC 12 mg/L) resistant.

ISSN: 1742-6405